FDA Signals New Testosterone Pathway

• by Kathryn Wighton

• April 16, 2026

Estriol may ease menopause-related cognitive decline

Women reported improvement across 6 cognitive domains during 12 months of estriol-based treatment, while murine models suggested a potential astrocyte-mediated mechanism.

• by Andrea Surnit

• September 3, 2026

• 3 min

Four Patterns in End-of-Life Decline?

International cohort study found physical function declined most rapidly before mortality, while socioeconomic status was associated with more favorable multidomain trajectories.

• by Andrea Surnit

• July 21, 2026

• 4 min

GLP-1 RAs Associated With Small ION Risk Increase

In an observational US target trial emulation, glucagon-like peptide-1 receptor agonist initiation was associated with about 3 to 4 more ischemic optic neuropathy cases per 10,000 patients over 18 months than two comparator drug classes.

• by Andrea Surnit

• July 13, 2026

• 5 min